Analysis

Mid-Day Market Update: InnerWorkings surges following merger news; Tricida shares plunge

Midway through trading Thursday, the Dow traded down 0.49% to 26738.29 while the NASDAQ fell 1.41% to 10,401.61. The S&P also fell, dropping 0.73% to 3,203.06.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 3,499,390 cases with around 137,410 deaths. Brazil confirmed a total of over 1,966,740 COVID-19 cases with 75,360 deaths, while India reported a total of at least 968,850 confirmed cases and 24,910 deaths. In total, there were at least 13,578,600 cases of COVID-19 worldwide with over 584,780 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Utilities shares rose 1% on Thursday. Meanwhile, top gainers in the sector included Azure Power Global Limited AZRE 6.57%, up 5%, and NextEra Energy, Inc. NEE 3.23%, up 3%.

In trading on Thursday, information technology shares fell 1.7%.

Top Headline

Bank of America Corp BAC 2.52% reported stronger-than-expected results for its second quarter.

Bank of America reported quarterly earnings of $0.37 per share, beating analysts’ estimates of $0.27 per share. The company reported sales of $22.30 billion, exceeding expectations of $22.01 billion.

Equities Trading UP

Boxlight Corporation BOXL 59.66% shares shot up 71% to $4.0799 after the company's website discussed a collaboration with Samsung.

Shares of Lion Financial Group Limited LGHL 45.62% got a boost, shooting 59% to $5.43 after the company reported the official launch of "Lion Lu Gu Tong," its total return swap service.

InnerWorkings, Inc. INWK 118.56% shares were also up, gaining 119% to $2.895 after HH Global announced plans to acquire the company for $3 per share.

Equities Trading DOWN

Tricida, Inc. TCDA 38.74% shares tumbled 38% to $16.25 after the company said it has received a notification from the FDA stating that, as part of its ongoing review of its New Drug Application for veverimer in metabolic acidosis, the FDA has identified deficiencies that preclude discussion of labeling and postmarketing requirements/commitments at this time.

Shares of INmune Bio, Inc. INMB 17.16% were down 16% to $10.98 after reporting a proposed public offering of common stock. INmune Bio shares jumped 78% on Tuesday following a positive clinical readout from the company.

Atreca, Inc. BCEL 18% was down, falling 17% to $15.26 after the company priced its 781,250 share common stock offering at $16 per share.

Commodities

In commodity news, oil traded down 0.5% to $41.01, while gold traded down 0.4% to $1,806.20.

Silver traded down 0.1% Thursday to $19.735, while copper rose 0.5% to $2.898.

Euro zone

European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.45%, the Spanish Ibex Index fell 0.2%, while Italy’s FTSE MIB Index gained 0.3%. Meanwhile, the German DAX 30 declined 0.38%, French CAC 40 fell 0.42% and UK shares fell 0.62%.

Economics

U.S. initial jobless claims eased slightly to 1.30 million in the week ended July 11, versus a revised 1.31 million claims in the previous week.

The Philadelphia Fed manufacturing index declined to 24.1 in July versus 27.5 in June.

U.S. retail sales climbed 7.5% in June versus a revised increase of 18.2% in May.

U.S. business inventories declined 2.3% in May versus a revised 1.4% drop in April.

The NAHB housing market index rose 14 points to a reading of 72 in July.

Domestic supplies of natural gas gained 45 billion cubic feet for the week ended July 10, the U.S. Energy Information Administration reported. However, analysts expected a rise of 50 billion cubic feet.

Chicago Federal Reserve chief Charles Evans is set to speak at 1:30 p.m. ET.

Federal Reserve Bank of Atlanta President Raphael Bostic will speak at 2:00 p.m. ET.

The Treasury International Capital report for May is scheduled for release at 4:00 p.m. ET.

Data on money supply for the recent week will be released at 4:30 p.m. ET.

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.


RELATED CONTENT

Loading ...



Copyright © 2024 FOREXSTREET S.L., All rights reserved.